Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer

Lessons Learned In terms of efficacy and safety, good results were obtained with S‐1 and paclitaxel (PTX) combination therapy. The findings suggest that S‐1 and PTX combination therapy is a feasible treatment option in patients with previously treated non‐small cell lung cancer. Background Although...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2019-08, Vol.24 (8), p.1033-e617
Hauptverfasser:	Chihara, Yusuke, Yoshimura, Akihiro, Date, Koji, Takemura, Yoshizumi, Tamiya, Nobuyo, Kohno, Yoshihito, Imabayashi, Tatsuya, Takeuchi, Mayumi, Kaneko, Yoshiko, Yamada, Tadaaki, Ueda, Mikio, Arimoto, Taichiro, Uchino, Junji, Iwasaki, Yoshinobu, Takayama, Koichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Trial Results
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!